1
Charles Hilaire Rivard, Ariel Dujovne: Mobile dynamic system for treating spinal disorder. Hopital Sainte Justine, Robert Mitchell, Kevin P Murphy, Swabey Ogilvy Renault, April 29, 2003: US06554831 (370 worldwide citation)

A mobile dynamic implantable spinal apparatus comprising at least one fixed bracket secured on a correcting rod and at least one mobile carrier slidably mounted on the correcting rod. The fixed bracket and the mobile carrier each include a body and a pedicle screw or a transverse process hook articu ...


2
Ernest G Seidman, Yves Théorêt: Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage. Hopital Sainte Justine, Campbell & Flores, March 12, 2002: US06355623 (39 worldwide citation)

The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level ...


3
Krishna G Peri, Sylvain Chemtob, Michel Potier: Antagonists of G-protein-coupled receptor. Hopital Sainte Justine, France Cote, Swabey Ogilvy Renault, September 21, 1999: US05955575 (10 worldwide citation)

The present invention relates to a new class of G-protein-coupled receptor antagonists which bind to the intracellular molecular interface between the receptor and the G-protein, thus hampering signal transduction. The present invention describes peptide sequences derived from the prostaglandin rece ...


4
Rivard Charles Hilaire, Dujovne Ariel: Mobile dynamic anchoring assembly for connecting an implantable rod with a bone. Hopital Sainte Justine, June 7, 2006: EP1665994-A1 (5 worldwide citation)

The present invention relates to a mobile dynamic anchoring assembly for connecting an implantable rod with a bone, characterized in that the assembly comprises a carrier adapted to be mounted to an implantable rod for sliding movement thereon and limited pivotal movement with respect thereto about ...


5
Richard L Momparler, Josee Laliberte, Denis Cournoyer, Nicoletta Eliopoulos: Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis. Hopital Sainte Justine, France Cote, Swabey Ogilvy Renault, July 4, 2000: US06083719 (4 worldwide citation)

The present invention relates to a DNA sequence for the human cytidine deaminase that has been engineered into an eukaryotic expression vector, thereby permitting cytidine deaminase expression in mammalian cells. Cytidine deaminase expression confers resistance to cytosine nucleoside analogs, such a ...


6
Rivard Charles Hilaire, Dujovne Ariel: Mobile dynamic system for treating spinal disorder. Hopital Sainte Justine, May 28, 2003: EP1313403-A2 (4 worldwide citation)

A mobile dynamic implantable spinal apparatus (10) comprising at least one fixed bracket (16a) secured on a correcting rod (12) and at least one mobile carrier (18a) slidably mounted on the correcting rod (12). The fixed bracket (16a) and the mobile carrier (18a) each include a body and a pedicle sc ...


7
Ernest G Seidman, Yves Theoret: Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders. Hopital Sainte Justine, Townsend Townsend and Crew, February 5, 2008: US07326694 (2 worldwide citation)

The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level ...


8
Krishna G Peri, Sylvain Chemtob: Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis. Hopital Sainte Justine, Klauber & Jackson, October 28, 2008: US07442763 (1 worldwide citation)

The present invention relates to a composition of matter comprising novel prostaglandin E2 receptor antagonists, and their use in treatments for regulating the fluid filtration in the kidney, preventing bone mineral loss in osteoporosis and dental disease and additionally, closure of ductus arterios ...


9
Ernest G Seidman, Yves Theoret: Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders. Hopital Sainte Justine, Townsend and Townsend and Crew, December 1, 2009: US07625876 (1 worldwide citation)

The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level ...


10
Ernest G Seidman, Yves Theoret: Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders. Hopital Sainte Justine, Townsend and Townsend and Crew, September 30, 2008: US07429570 (1 worldwide citation)

The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level ...